Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

Condition:   Breast Cancer Interventions:   Drug: Ribociclib Placebo;   Drug: Ribociclib;   Drug: NSAI: Letrozole or Anastrazole;   Drug: Letrozole;   Drug: Goserelin Sponsor:   Novartis Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials